Status: Recruiting
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
Participants needed: 190
Trial details
Phase: Phase 2Age: 18-44Biological sex: FemaleType: InterventionalSponsor: Gesynta Pharma ABUpdated: Sep 11, 2026Locations: 44
Eligibility criteria
Premenopausal females 18 to < 45 years of age at the time of Visit 1. [+4]
Chronic pelvic pain that is not judged to be primarily related to endometriosis... [+1]